These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 17927954

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Molecular interactions of dendrimers with amyloid peptides: pH dependence.
    Klajnert B, Cladera J, Bryszewska M.
    Biomacromolecules; 2006 Jul; 7(7):2186-91. PubMed ID: 16827586
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Conversion of non-fibrillar beta-sheet oligomers into amyloid fibrils in Alzheimer's disease amyloid peptide aggregation.
    Benseny-Cases N, Cócera M, Cladera J.
    Biochem Biophys Res Commun; 2007 Oct 05; 361(4):916-21. PubMed ID: 17679138
    [Abstract] [Full Text] [Related]

  • 6. Influence of heparin and dendrimers on the aggregation of two amyloid peptides related to Alzheimer's and prion diseases.
    Klajnert B, Cortijo-Arellano M, Bryszewska M, Cladera J.
    Biochem Biophys Res Commun; 2006 Jan 13; 339(2):577-82. PubMed ID: 16310169
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Conformational plasticity of the Gerstmann-Sträussler-Scheinker disease peptide as indicated by its multiple aggregation pathways.
    Natalello A, Prokorov VV, Tagliavini F, Morbin M, Forloni G, Beeg M, Manzoni C, Colombo L, Gobbi M, Salmona M, Doglia SM.
    J Mol Biol; 2008 Sep 19; 381(5):1349-61. PubMed ID: 18619462
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Full-length prion protein aggregates to amyloid fibrils and spherical particles by distinct pathways.
    El Moustaine D, Perrier V, Smeller L, Lange R, Torrent J.
    FEBS J; 2008 May 19; 275(9):2021-31. PubMed ID: 18355314
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Identification and characterization of a spontaneously aggregating amyloid-forming variant of human PrP((90-231)) through phage-display screening of variants randomized between residues 101 and 112.
    Verma A, Sharma S, Ganguly NK, Majumdar S, Guptasarma P, Luthra-Guptasarma M.
    Int J Biochem Cell Biol; 2008 May 19; 40(4):663-76. PubMed ID: 18023239
    [Abstract] [Full Text] [Related]

  • 16. In vitro characterization of lactoferrin aggregation and amyloid formation.
    Nilsson MR, Dobson CM.
    Biochemistry; 2003 Jan 21; 42(2):375-82. PubMed ID: 12525164
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Polyanion induced fibril growth enables the development of a reproducible assay in solution for the screening of fibril interfering compounds, and the investigation of the prion nucleation site.
    Boshuizen RS, Morbin M, Mazzoleni G, Tagliavini F, Meloen RH, Langedijk JP.
    Amyloid; 2007 Sep 21; 14(3):205-19. PubMed ID: 17701468
    [Abstract] [Full Text] [Related]

  • 19. Time evolution of the aggregation process of peptides involved in neurodegenerative diseases and preventing aggregation effect of phosphorus dendrimers studied by EPR.
    Ottaviani MF, Mazzeo R, Cangiotti M, Fiorani L, Majoral JP, Caminade AM, Pedziwiatr E, Bryszewska M, Klajnert B.
    Biomacromolecules; 2010 Nov 08; 11(11):3014-21. PubMed ID: 20958001
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.